The role of somatostatin analogs in the management of Graves' ophthalmopathy

J Endocrinol Invest. 2003;26(8 Suppl):109-13.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Graves Disease / drug therapy*
  • Graves Disease / immunology
  • Humans
  • Immunologic Factors / therapeutic use*
  • Octreotide / therapeutic use
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use

Substances

  • Immunologic Factors
  • Somatostatin
  • Octreotide